These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1282423)

  • 1. [Ways of prolonging the action of neuropeptide].
    Ashmarin IP
    Vestn Ross Akad Med Nauk; 1992; (8):7-10. PubMed ID: 1282423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal drug targeting of hypocretin-1 (orexin-A) to the central nervous system.
    Dhuria SV; Hanson LR; Frey WH
    J Pharm Sci; 2009 Jul; 98(7):2501-15. PubMed ID: 19025760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of the neuro- and immunomodulator properties of low-molecular neuropeptides].
    Kukaĭn EM; Mutsenietse RK; Klusha VE
    Biull Eksp Biol Med; 1982 Aug; 94(8):79-82. PubMed ID: 6127128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of porcine Orexin A on insulin plasma concentrations in pigs.
    Papakonstantinou P; Tziris N; Kesisoglou I; Gotzamani-Psarrakou A; Tsonidis C; Patsikas MN; Papazoglou LG
    J Biol Regul Homeost Agents; 2007; 21(3-4):115-24. PubMed ID: 18261263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revealing the potential of intranasally administered orexin A (hypocretin-1).
    Hallschmid M; Born J
    Mol Interv; 2008 Jun; 8(3):133-7. PubMed ID: 18693191
    [No Abstract]   [Full Text] [Related]  

  • 6. [The inverse immunoregulation of behavior and the problem of the existence of regulatory autoantibodies].
    Danilova RA; Ashmarin IP
    Usp Fiziol Nauk; 1994; 25(1):3-23. PubMed ID: 7913277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pituitary adenylate cyclase-activating polypeptide 38 (PACAP38) on tissue oxygen content--treatment in central nervous system of mice.
    Ohtaki H; Dohi K; Yofu S; Nakamachi T; Kudo Y; Endo S; Aruga T; Goto N; Watanabe J; Kikuyama S; Shioda S
    Regul Pept; 2004 Dec; 123(1-3):61-7. PubMed ID: 15518894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary adenylate cyclase-activating polypeptide enhances Ca(2+)-dependent neurotransmitter release from PC12 cells and cultured cerebellar granule cells without affecting intracellular Ca(2+) mobilization.
    Aoyagi K; Takahashi M
    Biochem Biophys Res Commun; 2001 Aug; 286(3):646-51. PubMed ID: 11511109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intranasal hypocretin-1 (orexin A) on sleep in narcolepsy with cataplexy.
    Baier PC; Hallschmid M; Seeck-Hirschner M; Weinhold SL; Burkert S; Diessner N; Göder R; Aldenhoff JB; Hinze-Selch D
    Sleep Med; 2011 Dec; 12(10):941-6. PubMed ID: 22036605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral effects of local microinfusion of pituitary adenylate cyclase activating polypeptide (PACAP) into the paraventricular nucleus of the hypothalamus (PVN).
    Norrholm SD; Das M; Légrádi G
    Regul Pept; 2005 May; 128(1):33-41. PubMed ID: 15721485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide S as a novel arousal promoting peptide transmitter.
    Reinscheid RK; Xu YL
    FEBS J; 2005 Nov; 272(22):5689-93. PubMed ID: 16279934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel vasoconstrictor formulation to enhance intranasal targeting of neuropeptide therapeutics to the central nervous system.
    Dhuria SV; Hanson LR; Frey WH
    J Pharmacol Exp Ther; 2009 Jan; 328(1):312-20. PubMed ID: 18945930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effect of orexin-A is mediated by an increase of hypoxia-inducible factor-1 activity in rat.
    Yuan LB; Dong HL; Zhang HP; Zhao RN; Gong G; Chen XM; Zhang LN; Xiong L
    Anesthesiology; 2011 Feb; 114(2):340-54. PubMed ID: 21239965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal delivery of neuropeptides.
    Veronesi MC; Kubek DJ; Kubek MJ
    Methods Mol Biol; 2011; 789():303-12. PubMed ID: 21922417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of peptide bioregulators for cancer prevention: results of 35 years of research experience and perspectives].
    Anisimov VN; Khavinson VKh
    Vopr Onkol; 2009; 55(3):291-304. PubMed ID: 19670728
    [No Abstract]   [Full Text] [Related]  

  • 16. Pituitary adenylate cyclase activating polypeptide is a potent calmodulin inhibitor.
    Au TK; Leung PC
    Biochem Biophys Res Commun; 1995 Mar; 208(1):280-6. PubMed ID: 7887941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of gastric acid secretion by central administration of FMRFamide in rats.
    Muthal AV; Chopde CT
    Indian J Med Res; 1993 Aug; 98():185-7. PubMed ID: 7903282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of macrophage-mediated tumoricidal activity by neuropeptides and neurohormones.
    Koff WC; Dunegan MA
    J Immunol; 1985 Jul; 135(1):350-4. PubMed ID: 2582037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of neurohumoral substances on specific leukocytolysis].
    Shatilova NV; Frolov EP; Undritsov MI
    Patol Fiziol Eksp Ter; 1974 May; 10(2):60-2. PubMed ID: 4151961
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunoregulatory agents: synthetic compounds, microbial extracts, Chinese herbs, neuropeptides and intravenous immunoglobulins.
    Wybran J
    Curr Opin Immunol; 1988 Dec; 1(2):275-81. PubMed ID: 2478156
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.